Form D · Pharmaceuticals
Patients' & Consumers' Pharmaceutical Company, Inc.
Dayton, OH · CIK 0001641873
Offering snapshot reported Jul 27, 2018 · SEC filing
- Reported sold
- $850K Offering amount: $1.2M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 13, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 27, 2018 | Initial | $850,000 | No comparison | 8 | SEC filing |
| May 20, 2016 | Initial | $2,209,232 | No comparison | 11 | SEC filing |
| Feb 19, 2016 | Amendment | $550,000 | $245,000vs Jul 6, 2015 | 5 | SEC filing |
| Oct 29, 2015 | Amendment | $505,000 | $200,000vs Jul 6, 2015 | 4 | SEC filing |
| Jul 6, 2015 | Amendment | $305,000 | $200,000vs Jun 4, 2015 | 4 | SEC filing |
| Jun 4, 2015 | Amendment | $105,000 | $0vs Jun 3, 2015 | 3 | SEC filing |
| Jun 3, 2015 | Initial | $105,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-317916
Source: Form D, filed Jul 27, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kend Anderson | Director |
| Kent Anderson | Director |
| Brent Atwood | Director, Executive |
| Joseph B D'silva | Director, Executive |
| Roger Edwards | Director, Executive |
| Roger A Edwwards | Director |
| Bradley M Norris | Director |
| Brad M. Norris | Director |
| Mike Shane | Director |
| Michael Sieron | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
955 Congress Park Drive
Dayton, OH, 45459
Dayton, OH, 45459